NumerixS Investment Technologies’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

NumerixS Investment Technologies’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-800	Closed	-$9K	–	1338
2020 Q1	$9K	Buy	+800	New	+$14.9K	﹤0.01%	901
2019 Q4	–	Sell	-3,490	Closed	-$80K	–	1280
2019 Q3	$80K	Buy	3,490 +1,000	+40%	+$31.5K	0.02%	618
2019 Q2	$76K	Sell	2,490 -3,510	-59%	-$73.9K	0.02%	679
2019 Q1	$98K	Buy	+6,000	New	+$114K	0.01%	867
2018 Q4	–	Sell	-4,000	Closed	-$219K	–	1445
2018 Q3	$219K	Buy	+4,000	New	+$218K	0.04%	554

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

NumerixS Investment Technologies's GTHX Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2020, closing a stake of 800 shares — an estimated $9K sold.

NumerixS Investment Technologies first reported a position in GTHX in Q3 2018 and held it in 5 quarters. The position peaked at $219K in Q3 2018. 100 funds tracked by Wall St. Rank hold GTHX as of Q2 2020.

NumerixS Investment Technologies reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 800 G1 Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $9K.
NumerixS Investment Technologies first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
NumerixS Investment Technologies's G1 Therapeutics, Inc. Common Stock position peaked at $219K in Q3 2018.
100 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.